|
1
|
Deng MY, Sill M, Sturm D, Stichel D, Witt
H, Ecker J, Wittmann A, Schittenhelm J, Ebinger M, Schuhmann MU, et
al: Diffuse glioneuronal tumour with oligodendroglioma-like
features and nuclear clusters (DGONC)-a molecularly-defined
glioneuronal CNS tumour class displaying recurrent monosomy 14.
Neuropathol Appl Neurobiol. 46:422–430. 2019. View Article : Google Scholar
|
|
2
|
Xi J, Sun Q, Ma L and Kang J: Long
non-coding RNAs in glioma progression. Cancer Lett. 419:203–209.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saxena S and Jha S: Role of NOD-like
receptors in glioma angiogenesis: Insights into future therapeutic
interventions. Cytokine Growth Factor Rev. 34:15–26. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rynkeviciene R, Simiene J, Strainiene E,
Stankevicius V, Usinskiene J, Miseikyte Kaubriene E, Meskinyte I,
Cicenas J and Suziedelis K: Non-coding RNAs in glioma. Cancers
(Basel). 11:172018. View Article : Google Scholar
|
|
7
|
Wang Q, Li Q, Zhou P, Deng D, Xue L, Shao
N, Peng Y and Zhi F: Upregulation of the long non-coding RNA SNHG1
predicts poor prognosis, promotes cell proliferation and invasion,
and reduces apoptosis in glioma. Biomed Pharmacother. 91:906–911.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao Y, Yu H, Liu Y, Liu X, Zheng J, Ma J,
Gong W, Chen J, Zhao L, Tian Y and Xue Y: Long non-coding RNA
HOXA-AS2 regulates malignant glioma behaviors and vasculogenic
mimicry formation via the MiR-373/EGFR axis. Cell Physiol Biochem.
45:131–147. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lorenzen JM and Thum T: Long noncoding
RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol.
12:360–373. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun W, Yang Y, Xu C and Guo J: Regulatory
mechanisms of long noncoding RNAs on gene expression in cancers.
Cancer Genet. 216-217:105–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dastmalchi N, Safaralizadeh R and Nargesi
MM: LncRNAs: Potential novel prognostic and diagnostic biomarkers
in colorectal cancer. Curr Med Chem. 27:5067–5077. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Q, Gong W, Wang J, Ji K, Sun X, Xu C,
Du L, Wang Y and Liu Q: Analysis of changes to lncRNAs and their
target mRNAs in murine jejunum after radiation treatment. J Cell
Mol Med. 22:6357–6367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sallam T, Jones M, Thomas BJ, Wu X,
Gilliland T, Qian K, Eskin A, Casero D, Zhang Z, Sandhu J, et al:
Transcriptional regulation of macrophage cholesterol efflux and
atherogenesis by a long noncoding RNA. Nat Med. 24:304–312. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li R and Fox AH: SPArking interest in the
long noncoding RNA world: A new class of 5′SnoRNA-stabilized LncRNA
that influences alternative splicing. Mol Cell. 64:435–437. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu ZM, Huang F and Huang WQ: Angiogenic
lncRNAs: A potential therapeutic target for ischaemic heart
disease. Life Sci. 211:157–171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tripathi MK, Doxtater K, Keramatnia F,
Zacheaus C, Yallapu MM, Jaggi M and Chauhan SC: Role of lncRNAs in
ovarian cancer: Defining new biomarkers for therapeutic purposes.
Drug Discov Today. 23:1635–1643. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamang S, Acharya V, Roy D, Sharma R,
Aryaa A, Sharma U, Khandelwal A, Prakash H, Vasquez KM and Jain A:
SNHG12: An LncRNA as a potential therapeutic target and biomarker
for human cancer. Front Oncol. 9:9012019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Wang R, Zhang K and Chen LB: Long
non-coding RNAs in non-small cell lung cancer as biomarkers and
therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang B, Bai Q, Chen H, Su K and Gao C:
LINC00665 induces gastric cancer progression through activating Wnt
signaling pathway. J Cell Biochem. 121:2268–2276. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qi H, Xiao Z and Wang Y: Long non-coding
RNA LINC00665 gastric cancer tumorigenesis by regulation
miR-149-3p/RNF2 axis. Onco Targets Ther. 12:6981–6990. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Lu X, Zhen F, Jin S, Yu T, Zhu Q,
Wang W, Xu K, Yao J and Guo R: LINC00665 induces acquired
resistance to gefitinib through recruiting EZH2 and activating
PI3K/AKT pathway in NSCLC. Mol Ther Nucleic Acids. 16:155–161.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cong Z, Diao Y, Xu Y, Li X, Jiang Z, Shao
C, Ji S, Shen Y, De W and Qiang Y: Long non-coding RNA linc00665
promotes lung adenocarcinoma progression and functions as ceRNA to
regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis.
10:842019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shan Y and Li P: Long intergenic
non-protein coding RNA 665 regulates viability, apoptosis, and
autophagy via the MiR-186-5p/MAP4K3 axis in hepatocellular
carcinoma. Yonsei Med J. 60:842–853. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cui CL, Li YN, Cui XY and Wu X: lncRNA
XIST promotes the progression of laryngeal squamous cell carcinoma
by sponging miR-144 to regulate IRS1 expression. Oncol Rep.
43:525–535. 2020.PubMed/NCBI
|
|
27
|
Bao W, Cao F, Ni S, Yang J, Li H, Su Z and
Zhao B: lncRNA FLVCR1-AS1 regulates cell proliferation, migration
and invasion by sponging miR-485-5p in human cholangiocarcinoma.
Oncol Lett. 18:2240–2247. 2019.PubMed/NCBI
|
|
28
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao H, Wang L, Zhan H, Dai J, Chang Y, Wu
F, Liu T, Liu Z, Gao C, Li L and Song X: A long noncoding RNA
distributed in both nucleus and cytoplasm operates in the
PYCARD-regulated apoptosis by coordinating the epigenetic and
translational regulation. PLoS Genet. 15:e10081442019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu H, Zhao G, Zhang Y, Jiang H, Wang W,
Zhao D, Yu H and Qi L: Long non-coding RNA PAXIP1-AS1 facilitates
cell invasion and angiogenesis of glioma by recruiting
transcription factor ETS1 to upregulate KIF14 expression. J Exp
Clin Cancer Res. 38:4862019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Q, Yu W, Zhu S, Cheng K, Xu H, Lv Y,
Long X, Ma L, Huang J, Sun S and Wang K: Long noncoding RNA GAS5
regulates the proliferation, migration, and invasion of glioma
cells by negatively regulating miR-18a-5p. J Cell Physiol.
234:757–768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Guo W, Xue W, Xu P, Deng Z, Zhang D,
Zheng S and Qiu X: Long noncoding RNA AURKAPS1 potentiates
malignant hepatocellular carcinoma progression by regulating
miR-142, miR-155 and miR-182. Sci Rep. 9:196452019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Jiang F, Xiong Y, Cheng X, Qiu Z
and Song R: LncRNA TTN-AS1 sponges miR-376a-3p to promote
colorectal cancer progression via upregulating KLF15. Life Sci.
244:1169362020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma S, Fu T, Zhao S and Gao M:
MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma
and potentiates Temozolomide-induced cytotoxicity for glioma cells
by targeting HMGA2. Eur J Pharmacol. 852:42–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu H, Zhang Y, Qi L, Ding L, Jiang H and
Yu H: NFIX circular RNA promotes glioma progression by regulating
miR-34a-5p via notch signaling pathway. Front Mol Neurosci.
11:2252018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Di Bari M, Bevilacqua V, De Jaco A, Laneve
P, Piovesana R, Trobiani L, Talora C, Caffarelli E and Tata AM:
Mir-34a-5p mediates cross-talk between M2 muscarinic receptors and
notch-1/EGFR pathways in U87MG glioblastoma cells: Implication in
cell proliferation. Int J Mol Sci. 19:16312018. View Article : Google Scholar
|
|
38
|
Ma Y, Xia Z, Ye C, Lu C, Zhou S, Pan J,
Liu C, Zhang J, Liu T, Hu T, et al: AGTR1 promotes lymph node
metastasis in breast cancer by upregulating CXCR4/SDF-1α and
inducing cell migration and invasion. Aging (Albany NY).
11:3969–3992. 2019. View Article : Google Scholar : PubMed/NCBI
|
